chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 12.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-Jul-2022) and NO ADVERSE EVENT (No adverse event) in a 12-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis. No Medical History information was reported. On 22-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 22-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-Jul-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 22-Jul-2022). No concomitant medications were provided by the reporter. Patient received full dose. Vial was initially stored in the refrigerator on 04-Jun-2022. Vaccine administered to 346 patients after the 30 days by used involved 35 vials. Vial did not undergo any temperature excursions. No treatment medications were provided by the reporter.
Age: 57.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The patient administered the vaccine after the 30 days by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 05-Jul-2022) and NO ADVERSE EVENT (No adverse event) in a 57-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis. No Medical History information was reported. On 05-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 05-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (The patient administered the vaccine after the 30 days by used). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 05-Jul-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (The patient administered the vaccine after the 30 days by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 05-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (The patient administered the vaccine after the 30 days by used) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 05-Jul-2022). No concomitant product use was reported. The patient received half dose. The vial had not undergone any temperature excursions. No treatment information was provided.
Age: 57.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The patient administered the vaccine after the 30 days by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 05-Jul-2022) and NO ADVERSE EVENT (No adverse event) in a 57-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis. No Medical History information was reported. On 05-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 05-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (The patient administered the vaccine after the 30 days by used). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 05-Jul-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (The patient administered the vaccine after the 30 days by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 05-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (The patient administered the vaccine after the 30 days by used) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 05-Jul-2022). No concomitant product use was reported. The patient received half dose. The vial had not undergone any temperature excursions. No treatment information was provided.
Age: 68.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered the vaccine after the 30 day use by date), PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 4-Jun-2022 and administered past 30 day use by date) and NO ADVERSE EVENT (No adverse event) in a 68-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis. No Medical History information was reported. On 28-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 28-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered the vaccine after the 30 day  use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 4-Jun-2022 and administered past 30 day use by date) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered the vaccine after the 30 day use by date), PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 4-Jun-2022 and administered past 30 day use by date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Administered the vaccine after the 30 day use by date) and PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 4-Jun-2022 and administered past 30 day use by date). No concomitant product use was reported. Patient received half dose. Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 28-Jul-2022. Total 35 vials were affected. Vial did not undergo any temperature excursions. No treatment information was provided.
Age: 68.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered the vaccine after the 30 day use by date), PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 4-Jun-2022 and administered past 30 day use by date) and NO ADVERSE EVENT (No adverse event) in a 68-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis. No Medical History information was reported. On 28-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 28-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered the vaccine after the 30 day  use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 4-Jun-2022 and administered past 30 day use by date) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered the vaccine after the 30 day use by date), PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 4-Jun-2022 and administered past 30 day use by date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Administered the vaccine after the 30 day use by date) and PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 4-Jun-2022 and administered past 30 day use by date). No concomitant product use was reported. Patient received half dose. Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 28-Jul-2022. Total 35 vials were affected. Vial did not undergo any temperature excursions. No treatment information was provided.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Blood blister, Chills, Diarrhoea, Dizziness
Clinical narrative: This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 68-year-old female patient received BNT162b2 (BNT162B2), on 31Jul2022 as dose number unknown (booster), single (Lot number: FP7138) at the age of 68 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer), for COVID-19 immunization; Bnt162b2 (DOSE NUMBER UNKNOWN (BOOSTER), SINGLE), for COVID-19 immunization. The following information was reported: NAUSEA (non-serious) with onset 2022, outcome "unknown", described as "I also had Nausea, I felt nauseated."; VACCINATION SITE SWELLING (non-serious) with onset 2022, outcome "unknown", described as "I also have like the injection site itself, it was raised, it raised like a big welled"; DIARRHOEA (non-serious) with onset 2022, outcome "unknown", described as "I had Diarrhea"; PAIN IN EXTREMITY (non-serious) with onset 2022, outcome "unknown", described as "My arm was just sore, I can barely drive."; ALLERGY TO VACCINE (non-serious) with onset 2022, outcome "unknown", described as "it is almost like an allergic reaction"; TOXICITY TO VARIOUS AGENTS (non-serious) with onset 2022, outcome "unknown", described as "like it is almost like a poison where ever you itch and itching really very bad"; PRURITUS ALLERGIC (non-serious) with onset 2022, outcome "unknown", described as "my neck, my torso, my arms, I am just itching / like an allergic reaction where you really itch"; RASH (non-serious), FEELING HOT (non-serious) all with onset 2022, outcome "unknown" and all described as "rash on my arm and the area was hot"; HEADACHE (non-serious) with onset 04Aug2022, outcome "unknown"; VACCINATION SITE VESICLES (non-serious) with onset 05Aug2022, outcome "unknown", described as "where the needle went in, I developed a blood blister". Relevant laboratory tests and procedures are available in the appropriate section. Additional information: The patient was having a really bad experience almost like an allergic reaction; her neck, torso, arms--she was just itching like an allergic reaction where you really itch. She also had nausea; she felt nauseated. She had diarrhea but that was for the first two and three days. The patient went through a headache last 04Aug2022. Her arm was just sore, she could barely drive. The injection site was raised like a big welled (as reported). She had a rash on her arm and the area was hot. It was itching terribly. On 05Aug2022, the patient noticed that she developed a blood blister on the area where the needle went in. She was currently on day seven on 06Aug2022 and she was still almost like a poison wherever she itches and itching was really very bad. She had not done any lab work since the vaccination; the last one was several months ago. The patient was worried and nervous about taking another booster because she was just itching so bad.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site rash, Injection site swelling, Myalgia, Nausea, Pyrexia
Clinical narrative: This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 68-year-old female patient received BNT162b2 (BNT162B2), on 31Jul2022 as dose number unknown (booster), single (Lot number: FP7138) at the age of 68 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer), for COVID-19 immunization; Bnt162b2 (DOSE NUMBER UNKNOWN (BOOSTER), SINGLE), for COVID-19 immunization. The following information was reported: NAUSEA (non-serious) with onset 2022, outcome "unknown", described as "I also had Nausea, I felt nauseated."; VACCINATION SITE SWELLING (non-serious) with onset 2022, outcome "unknown", described as "I also have like the injection site itself, it was raised, it raised like a big welled"; DIARRHOEA (non-serious) with onset 2022, outcome "unknown", described as "I had Diarrhea"; PAIN IN EXTREMITY (non-serious) with onset 2022, outcome "unknown", described as "My arm was just sore, I can barely drive."; ALLERGY TO VACCINE (non-serious) with onset 2022, outcome "unknown", described as "it is almost like an allergic reaction"; TOXICITY TO VARIOUS AGENTS (non-serious) with onset 2022, outcome "unknown", described as "like it is almost like a poison where ever you itch and itching really very bad"; PRURITUS ALLERGIC (non-serious) with onset 2022, outcome "unknown", described as "my neck, my torso, my arms, I am just itching / like an allergic reaction where you really itch"; RASH (non-serious), FEELING HOT (non-serious) all with onset 2022, outcome "unknown" and all described as "rash on my arm and the area was hot"; HEADACHE (non-serious) with onset 04Aug2022, outcome "unknown"; VACCINATION SITE VESICLES (non-serious) with onset 05Aug2022, outcome "unknown", described as "where the needle went in, I developed a blood blister". Relevant laboratory tests and procedures are available in the appropriate section. Additional information: The patient was having a really bad experience almost like an allergic reaction; her neck, torso, arms--she was just itching like an allergic reaction where you really itch. She also had nausea; she felt nauseated. She had diarrhea but that was for the first two and three days. The patient went through a headache last 04Aug2022. Her arm was just sore, she could barely drive. The injection site was raised like a big welled (as reported). She had a rash on her arm and the area was hot. It was itching terribly. On 05Aug2022, the patient noticed that she developed a blood blister on the area where the needle went in. She was currently on day seven on 06Aug2022 and she was still almost like a poison wherever she itches and itching was really very bad. She had not done any lab work since the vaccination; the last one was several months ago. The patient was worried and nervous about taking another booster because she was just itching so bad.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Throat irritation
Clinical narrative: This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 68-year-old female patient received BNT162b2 (BNT162B2), on 31Jul2022 as dose number unknown (booster), single (Lot number: FP7138) at the age of 68 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer), for COVID-19 immunization; Bnt162b2 (DOSE NUMBER UNKNOWN (BOOSTER), SINGLE), for COVID-19 immunization. The following information was reported: NAUSEA (non-serious) with onset 2022, outcome "unknown", described as "I also had Nausea, I felt nauseated."; VACCINATION SITE SWELLING (non-serious) with onset 2022, outcome "unknown", described as "I also have like the injection site itself, it was raised, it raised like a big welled"; DIARRHOEA (non-serious) with onset 2022, outcome "unknown", described as "I had Diarrhea"; PAIN IN EXTREMITY (non-serious) with onset 2022, outcome "unknown", described as "My arm was just sore, I can barely drive."; ALLERGY TO VACCINE (non-serious) with onset 2022, outcome "unknown", described as "it is almost like an allergic reaction"; TOXICITY TO VARIOUS AGENTS (non-serious) with onset 2022, outcome "unknown", described as "like it is almost like a poison where ever you itch and itching really very bad"; PRURITUS ALLERGIC (non-serious) with onset 2022, outcome "unknown", described as "my neck, my torso, my arms, I am just itching / like an allergic reaction where you really itch"; RASH (non-serious), FEELING HOT (non-serious) all with onset 2022, outcome "unknown" and all described as "rash on my arm and the area was hot"; HEADACHE (non-serious) with onset 04Aug2022, outcome "unknown"; VACCINATION SITE VESICLES (non-serious) with onset 05Aug2022, outcome "unknown", described as "where the needle went in, I developed a blood blister". Relevant laboratory tests and procedures are available in the appropriate section. Additional information: The patient was having a really bad experience almost like an allergic reaction; her neck, torso, arms--she was just itching like an allergic reaction where you really itch. She also had nausea; she felt nauseated. She had diarrhea but that was for the first two and three days. The patient went through a headache last 04Aug2022. Her arm was just sore, she could barely drive. The injection site was raised like a big welled (as reported). She had a rash on her arm and the area was hot. It was itching terribly. On 05Aug2022, the patient noticed that she developed a blood blister on the area where the needle went in. She was currently on day seven on 06Aug2022 and she was still almost like a poison wherever she itches and itching was really very bad. She had not done any lab work since the vaccination; the last one was several months ago. The patient was worried and nervous about taking another booster because she was just itching so bad.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Allergy to vaccine, Diarrhoea, Feeling hot, Headache, Laboratory test
Clinical narrative: This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 68-year-old female patient received BNT162b2 (BNT162B2), on 31Jul2022 as dose number unknown (booster), single (Lot number: FP7138) at the age of 68 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer), for COVID-19 immunization; Bnt162b2 (DOSE NUMBER UNKNOWN (BOOSTER), SINGLE), for COVID-19 immunization. The following information was reported: NAUSEA (non-serious) with onset 2022, outcome "unknown", described as "I also had Nausea, I felt nauseated."; VACCINATION SITE SWELLING (non-serious) with onset 2022, outcome "unknown", described as "I also have like the injection site itself, it was raised, it raised like a big welled"; DIARRHOEA (non-serious) with onset 2022, outcome "unknown", described as "I had Diarrhea"; PAIN IN EXTREMITY (non-serious) with onset 2022, outcome "unknown", described as "My arm was just sore, I can barely drive."; ALLERGY TO VACCINE (non-serious) with onset 2022, outcome "unknown", described as "it is almost like an allergic reaction"; TOXICITY TO VARIOUS AGENTS (non-serious) with onset 2022, outcome "unknown", described as "like it is almost like a poison where ever you itch and itching really very bad"; PRURITUS ALLERGIC (non-serious) with onset 2022, outcome "unknown", described as "my neck, my torso, my arms, I am just itching / like an allergic reaction where you really itch"; RASH (non-serious), FEELING HOT (non-serious) all with onset 2022, outcome "unknown" and all described as "rash on my arm and the area was hot"; HEADACHE (non-serious) with onset 04Aug2022, outcome "unknown"; VACCINATION SITE VESICLES (non-serious) with onset 05Aug2022, outcome "unknown", described as "where the needle went in, I developed a blood blister". Relevant laboratory tests and procedures are available in the appropriate section. Additional information: The patient was having a really bad experience almost like an allergic reaction; her neck, torso, arms--she was just itching like an allergic reaction where you really itch. She also had nausea; she felt nauseated. She had diarrhea but that was for the first two and three days. The patient went through a headache last 04Aug2022. Her arm was just sore, she could barely drive. The injection site was raised like a big welled (as reported). She had a rash on her arm and the area was hot. It was itching terribly. On 05Aug2022, the patient noticed that she developed a blood blister on the area where the needle went in. She was currently on day seven on 06Aug2022 and she was still almost like a poison wherever she itches and itching was really very bad. She had not done any lab work since the vaccination; the last one was several months ago. The patient was worried and nervous about taking another booster because she was just itching so bad.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vaccination site swelling, Vaccination site vesicles
Clinical narrative: This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 68-year-old female patient received BNT162b2 (BNT162B2), on 31Jul2022 as dose number unknown (booster), single (Lot number: FP7138) at the age of 68 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer), for COVID-19 immunization; Bnt162b2 (DOSE NUMBER UNKNOWN (BOOSTER), SINGLE), for COVID-19 immunization. The following information was reported: NAUSEA (non-serious) with onset 2022, outcome "unknown", described as "I also had Nausea, I felt nauseated."; VACCINATION SITE SWELLING (non-serious) with onset 2022, outcome "unknown", described as "I also have like the injection site itself, it was raised, it raised like a big welled"; DIARRHOEA (non-serious) with onset 2022, outcome "unknown", described as "I had Diarrhea"; PAIN IN EXTREMITY (non-serious) with onset 2022, outcome "unknown", described as "My arm was just sore, I can barely drive."; ALLERGY TO VACCINE (non-serious) with onset 2022, outcome "unknown", described as "it is almost like an allergic reaction"; TOXICITY TO VARIOUS AGENTS (non-serious) with onset 2022, outcome "unknown", described as "like it is almost like a poison where ever you itch and itching really very bad"; PRURITUS ALLERGIC (non-serious) with onset 2022, outcome "unknown", described as "my neck, my torso, my arms, I am just itching / like an allergic reaction where you really itch"; RASH (non-serious), FEELING HOT (non-serious) all with onset 2022, outcome "unknown" and all described as "rash on my arm and the area was hot"; HEADACHE (non-serious) with onset 04Aug2022, outcome "unknown"; VACCINATION SITE VESICLES (non-serious) with onset 05Aug2022, outcome "unknown", described as "where the needle went in, I developed a blood blister". Relevant laboratory tests and procedures are available in the appropriate section. Additional information: The patient was having a really bad experience almost like an allergic reaction; her neck, torso, arms--she was just itching like an allergic reaction where you really itch. She also had nausea; she felt nauseated. She had diarrhea but that was for the first two and three days. The patient went through a headache last 04Aug2022. Her arm was just sore, she could barely drive. The injection site was raised like a big welled (as reported). She had a rash on her arm and the area was hot. It was itching terribly. On 05Aug2022, the patient noticed that she developed a blood blister on the area where the needle went in. She was currently on day seven on 06Aug2022 and she was still almost like a poison wherever she itches and itching was really very bad. She had not done any lab work since the vaccination; the last one was several months ago. The patient was worried and nervous about taking another booster because she was just itching so bad.
Age: 61.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: Vial was initially stored in refrigerator on 4-Jun-2022 and administered on 13-Jul-2022; No adverse event; Administered the vaccine after the 30 day use by date; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered the vaccine after the 30 day use by date), PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 4-Jun-2022 and administered on 13-Jul-2022) and NO ADVERSE EVENT (No adverse event) in a 61-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 13-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 13-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered the vaccine after the 30 day use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 4-Jun-2022 and administered on 13-Jul-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered the vaccine after the 30 day use by date), PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 4-Jun-2022 and administered on 13-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Administered the vaccine after the 30 day use by date) and PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 4-Jun-2022 and administered on 13-Jul-2022).    No concomitant product use was reported.  It was reported that, patient received half dose. The vial did not undergo any temperature excursions.  The vial was initially stored in the refrigerator on 4 Jun 2022  No treatment information was provided.
Age: 61.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: Vial was initially stored in refrigerator on 4-Jun-2022 and administered on 13-Jul-2022; No adverse event; Administered the vaccine after the 30 day use by date; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered the vaccine after the 30 day use by date), PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 4-Jun-2022 and administered on 13-Jul-2022) and NO ADVERSE EVENT (No adverse event) in a 61-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 13-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 13-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered the vaccine after the 30 day use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 4-Jun-2022 and administered on 13-Jul-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered the vaccine after the 30 day use by date), PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 4-Jun-2022 and administered on 13-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Administered the vaccine after the 30 day use by date) and PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 4-Jun-2022 and administered on 13-Jul-2022).    No concomitant product use was reported.  It was reported that, patient received half dose. The vial did not undergo any temperature excursions.  The vial was initially stored in the refrigerator on 4 Jun 2022  No treatment information was provided.
Age: 59.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 06-JUL-2022; No adverse event; Administered the vaccine after the 30 day use by date; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered the vaccine after the 30 day use by date), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 06-JUL-2022) and NO ADVERSE EVENT (No adverse event) in a 59-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 06-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 06-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered the vaccine after the 30 day use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 06-JUL-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered the vaccine after the 30 day use by date), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 06-JUL-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Administered the vaccine after the 30 day use by date) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 06-JUL-2022).    No concomitant medications were reported.  The patient received half dose. The vial was initially stored in the refrigerator on 04-Jun-2022. Total 35 vials were affected. Reportedly, the vial did not undergo any temperature excursions.  No treatment information was provided by the reporter.
Age: 59.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 06-JUL-2022; No adverse event; Administered the vaccine after the 30 day use by date; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered the vaccine after the 30 day use by date), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 06-JUL-2022) and NO ADVERSE EVENT (No adverse event) in a 59-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 06-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 06-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered the vaccine after the 30 day use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 06-JUL-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered the vaccine after the 30 day use by date), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 06-JUL-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Administered the vaccine after the 30 day use by date) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 06-JUL-2022).    No concomitant medications were reported.  The patient received half dose. The vial was initially stored in the refrigerator on 04-Jun-2022. Total 35 vials were affected. Reportedly, the vial did not undergo any temperature excursions.  No treatment information was provided by the reporter.
Age: 56.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: vial was initially stored in the refrigerator on 4Jun2022 and administration of vaccine on 09Jul2022; No adverse event; Administered the vaccine to patient after the 30 day by used; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to patient after the 30 day by used), PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 4Jun2022 and administration of vaccine on 09Jul2022) and NO ADVERSE EVENT (No adverse event) in a 56-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 09-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 09-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to patient after the 30 day by used). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 4Jun2022 and administration of vaccine on 09Jul2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to patient after the 30 day by used), PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 4Jun2022 and administration of vaccine on 09Jul2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to patient after the 30 day by used) and PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 4Jun2022 and administration of vaccine on 09Jul2022).    No concomitant medication was reported by reporter.  Total 35 vials were affected. Vial was initially stored in refrigerator on 04-Jun-2022 and did not undergo temperature excursion. Manufacture code for the lot. Patient was administered with half dose.  No treatment medication was reported by reporter.
Age: 56.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: vial was initially stored in the refrigerator on 4Jun2022 and administration of vaccine on 09Jul2022; No adverse event; Administered the vaccine to patient after the 30 day by used; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to patient after the 30 day by used), PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 4Jun2022 and administration of vaccine on 09Jul2022) and NO ADVERSE EVENT (No adverse event) in a 56-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 09-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 09-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to patient after the 30 day by used). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 4Jun2022 and administration of vaccine on 09Jul2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to patient after the 30 day by used), PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 4Jun2022 and administration of vaccine on 09Jul2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to patient after the 30 day by used) and PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 4Jun2022 and administration of vaccine on 09Jul2022).    No concomitant medication was reported by reporter.  Total 35 vials were affected. Vial was initially stored in refrigerator on 04-Jun-2022 and did not undergo temperature excursion. Manufacture code for the lot. Patient was administered with half dose.  No treatment medication was reported by reporter.
Age: 76.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: The vial was initially stored in refrigerator was on 04-Jun-2022 and vaccine administered on 07-Jul-2022; No adverse event; Patient administered the vaccine after the 30 days by used; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 days by used), PRODUCT STORAGE ERROR (The vial was initially stored in refrigerator was on 04-Jun-2022 and vaccine administered on 07-Jul-2022) and NO ADVERSE EVENT (No adverse event) in a 76-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 07-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 07-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 days by used). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in refrigerator was on 04-Jun-2022 and vaccine administered on 07-Jul-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 days by used), PRODUCT STORAGE ERROR (The vial was initially stored in refrigerator was on 04-Jun-2022 and vaccine administered on 07-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 days by used) and PRODUCT STORAGE ERROR (The vial was initially stored in refrigerator was on 04-Jun-2022 and vaccine administered on 07-Jul-2022).    No concomitant product use was reported.  Patient received half dose.  Vial was initially stored in the refrigerator on 04-Jun-2022.  Vaccine administered to 346 patients after the 30 days by used involved 35 vials. Vial did not undergo any temperature excursions.  No treatment information was provided.
Age: 76.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: The vial was initially stored in refrigerator was on 04-Jun-2022 and vaccine administered on 07-Jul-2022; No adverse event; Patient administered the vaccine after the 30 days by used; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 days by used), PRODUCT STORAGE ERROR (The vial was initially stored in refrigerator was on 04-Jun-2022 and vaccine administered on 07-Jul-2022) and NO ADVERSE EVENT (No adverse event) in a 76-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 07-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 07-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 days by used). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in refrigerator was on 04-Jun-2022 and vaccine administered on 07-Jul-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 days by used), PRODUCT STORAGE ERROR (The vial was initially stored in refrigerator was on 04-Jun-2022 and vaccine administered on 07-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 days by used) and PRODUCT STORAGE ERROR (The vial was initially stored in refrigerator was on 04-Jun-2022 and vaccine administered on 07-Jul-2022).    No concomitant product use was reported.  Patient received half dose.  Vial was initially stored in the refrigerator on 04-Jun-2022.  Vaccine administered to 346 patients after the 30 days by used involved 35 vials. Vial did not undergo any temperature excursions.  No treatment information was provided.
Age: 43.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: Vial was initially stored in refrigerator on 4-Jun-2022 and administered past 30 day use by date; No adverse event; Administered the vaccine after the 30 day use by date; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered the vaccine after the 30 day use by date), PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 4-Jun-2022 and administered past 30 day use by date) and NO ADVERSE EVENT (No adverse event) in a 43-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 15-Jul-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) .5 milliliter. On 15-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered the vaccine after the 30 day use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 4-Jun-2022 and administered past 30 day use by date) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered the vaccine after the 30 day use by date), PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 4-Jun-2022 and administered past 30 day use by date) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Administered the vaccine after the 30 day use by date) and PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 4-Jun-2022 and administered past 30 day use by date).    Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 15-Jul-2022 No concomitant product use was reported. Patient received full dose. On 04-Jun-2022 the vials were initially stored in the refrigerator. Total 35 vials were affected. Vial did not undergo any temperature excursions. No treatment information was provided.
Age: 43.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: Vial was initially stored in refrigerator on 4-Jun-2022 and administered past 30 day use by date; No adverse event; Administered the vaccine after the 30 day use by date; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered the vaccine after the 30 day use by date), PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 4-Jun-2022 and administered past 30 day use by date) and NO ADVERSE EVENT (No adverse event) in a 43-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 15-Jul-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) .5 milliliter. On 15-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered the vaccine after the 30 day use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 4-Jun-2022 and administered past 30 day use by date) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered the vaccine after the 30 day use by date), PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 4-Jun-2022 and administered past 30 day use by date) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Administered the vaccine after the 30 day use by date) and PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 4-Jun-2022 and administered past 30 day use by date).    Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 15-Jul-2022 No concomitant product use was reported. Patient received full dose. On 04-Jun-2022 the vials were initially stored in the refrigerator. Total 35 vials were affected. Vial did not undergo any temperature excursions. No treatment information was provided.